Abstract:Hippocampal pyramidal neurons potentially express multiple subtypes of GABA(A) receptors at extrasynaptic locations that could therefore respond to different drugs. We activated extrasynaptic GABA(A) receptors in cultured rat hippocampal pyramidal neurons and measured single-channel currents in order to compare the actions of two drugs that potentially target different GABA(A) receptor subtypes. Despite the possible difference in receptor targets of etomidate and diazepam, the two drugs were similar in their a… Show more
“…Diazepam potentiation of the GABA current causes an increase in open probability; when the conductance is low (Ͻ40 pS), this is often accompanied by an increase in single-channel conductance (1,5). In the example shown in Fig.…”
Native GABA(A) channels display a single-channel conductance ranging between approximately 10 and 90 pS. Diazepam increases the conductance of some of these native channels but never those of recombinant receptors, unless they are coexpressed with GABARAP. This trafficking protein clusters recombinant receptors in the membrane, suggesting that high-conductance channels arise from receptors that are at locally high concentrations. The amphipathic (MA) helix that is present in the large cytoplasmic loop of every subunit of all ligand-gated ion channels mediates protein-protein interactions. Here we report that when applied to inside-out patches, a peptide mimicking the MA helix of the gamma2 subunit (gamma(381-403)) of the GABA(A) receptor abrogates the potentiating effect of diazepam on both endogenous receptors and recombinant GABA(A) receptors coexpressed with GABARAP, by substantially reducing their conductance. The protein interaction disrupted by the peptide did not involve GABARAP, because a shorter peptide (gamma(386-403)) known to compete with the gamma2-GABARAP interaction did not affect the conductance of recombinant alphabetagamma receptors coexpressed with GABARAP. The requirement for receptor clustering and the fact that the gamma2 MA helix is able to self-associate support a mechanism whereby adjacent GABA(A) receptors interact via their gamma2-subunit MA helices, altering ion permeation through each channel. Alteration of ion-channel function arising from dynamic interactions between ion channels of the same family has not been reported previously and highlights a novel way in which inhibitory neurotransmission in the brain may be differentially modulated.
“…Diazepam potentiation of the GABA current causes an increase in open probability; when the conductance is low (Ͻ40 pS), this is often accompanied by an increase in single-channel conductance (1,5). In the example shown in Fig.…”
Native GABA(A) channels display a single-channel conductance ranging between approximately 10 and 90 pS. Diazepam increases the conductance of some of these native channels but never those of recombinant receptors, unless they are coexpressed with GABARAP. This trafficking protein clusters recombinant receptors in the membrane, suggesting that high-conductance channels arise from receptors that are at locally high concentrations. The amphipathic (MA) helix that is present in the large cytoplasmic loop of every subunit of all ligand-gated ion channels mediates protein-protein interactions. Here we report that when applied to inside-out patches, a peptide mimicking the MA helix of the gamma2 subunit (gamma(381-403)) of the GABA(A) receptor abrogates the potentiating effect of diazepam on both endogenous receptors and recombinant GABA(A) receptors coexpressed with GABARAP, by substantially reducing their conductance. The protein interaction disrupted by the peptide did not involve GABARAP, because a shorter peptide (gamma(386-403)) known to compete with the gamma2-GABARAP interaction did not affect the conductance of recombinant alphabetagamma receptors coexpressed with GABARAP. The requirement for receptor clustering and the fact that the gamma2 MA helix is able to self-associate support a mechanism whereby adjacent GABA(A) receptors interact via their gamma2-subunit MA helices, altering ion permeation through each channel. Alteration of ion-channel function arising from dynamic interactions between ion channels of the same family has not been reported previously and highlights a novel way in which inhibitory neurotransmission in the brain may be differentially modulated.
“…The ability of 2′MeO6MF to directly activate native GABA A channels was examined in hippocampal neurons from the newborn rat. Pharmacological (Caraiscos et al ., 2004; Mangan et al ., 2005; Herd et al ., 2008; Seymour et al ., 2009) and competitor peptide experiments have shown that these neurons express multiple receptor subtypes including γ‐ and δ‐containing GABA A channels. Single‐channel currents in response to 2′MeO6MF were recorded from inside‐out patches pulled from cultured neurons and their characteristics compared with those observed with GABA.…”
Section: Resultsmentioning
confidence: 99%
“…In the present study, we examined the actions of an analogue of 6‐methylflavone, 2′methoxy‐6‐methylflavone (2′MeO6MF) on human recombinant α1–3,5β1–3γ2L and α1/2β2 GABA A receptors expressed in Xenopus oocytes and on native GABA A receptors in rat newborn hippocampal patches that express multiple receptor subtypes (Seymour et al ., 2009). In this study, we report that 2′MeO6MF positively modulates α1β1–3γ2L GABA A receptors, whereas at α2β2/3γ2L GABA A receptors, the flavonoid directly activates these receptors in the absence of GABA.…”
BACKGROUND AND PURPOSEFlavonoids are known to have anxiolytic and sedative effects mediated via actions on ionotropic GABA receptors. We sought to investigate this further.
EXPERIMENTAL APPROACHWe evaluated the effects of 2′-methoxy-6-methylflavone (2′MeO6MF) on native GABAA receptors in new-born rat hippocampal neurons and determined specificity from 18 human recombinant GABAA receptor subtypes expressed in Xenopus oocytes. We used ligand binding, two-electrode voltage clamp and patch clamp studies together with behavioural studies.
KEY RESULTS2′MeO6MF potentiated GABA at a2b1g2L and all a1-containing GABAA receptor subtypes. At a2b2/3g2L GABAA receptors, however, 2′MeO6MF directly activated the receptors without potentiating GABA. This activation was attenuated by bicuculline and gabazine but not flumazenil indicating a novel site. Mutation studies showed position 265 in the b1/2 subunit was key to whether 2′MeO6MF was an activator or a potentiator. In hippocampal neurons, 2′MeO6MF directly activated single-channel currents that showed the hallmarks of GABAA Cl -currents. In the continued presence of 2′MeO6MF the single-channel conductance increased and these high conductance channels were disrupted by the g2(381-403) MA peptide, indicating that such currents are mediated by a2/g2-containing GABAA receptors. In mice, 2′MeO6MF (1-100 mg·kg -1 ; i.p.) displayed anxiolytic-like effects in two unconditioned models of anxiety: the elevated plus maze and light/dark tests. 2′MeO6MF induced sedative effects at higher doses in the holeboard, actimeter and barbiturate-induced sleep time tests. No myorelaxant effects were observed in the horizontal wire test.
CONCLUSIONS AND IMPLICATIONS2′MeO6MF will serve as a tool to study the complex nature of the activation and modulation of GABAA receptor subtypes.
“…Electrophysiological studies demonstrated that a clinically relevant concentration etomidate either enhanced the amplitude of GABA-evoked Cl -currents or increased the GABAergic inhibitory transmission [1][2][3][4][5]. In cultured hippocampal neurons, etomidate potentiated GABA-evoked currents by increasing the open probability, conductance and the open time of single channel [6,7]. In mammalian cerebellar cortex, MILs provide dendritic and somatic inhibition of PCs through the activation of GABA A receptors, indicating that GABA A receptors activity play a critical role in regulation of PCs activity [22].…”
“…Electrophysiological studies showed that etomidate either enhanced the amplitude of Cl -currents evoked by application of GABA, or increased GABAergic inhibitory transmission [1][2][3][4][5]. At a clinically relevant concentration of etomidate, potentiated GABA currents resulted in increases in open probability, membrane conductance and the open time of single GABA channel in cultured hippocampal neurons [6,7]. In rat spinal dorsal horn neurons, the etomidate actions were concentration-dependent: etomidate at 10 μmol\L potentiated GABA-activated current, slowed activation, desensitization and deactivation of GABA A receptors; etomidate at 10-1,000 μmol\L directly activated and desensitized GABA A receptors [1].…”
Etomidate is an imidazole, nonbarbiturate hypnotic agent that is increasingly used in procedural sedation. However, the effects of etomidate on the spontaneous activity of cerebellar Purkinje cells (PCs) in living mouse have not been fully understood. In this study, we investigated the effects of etomidate on the spontaneous simple spike (SS) activity of PCs in urethane-anesthetized mice by cell-attached recording and pharmacological methods. Cerebellar surface application of etomidate (50 μmol\L) reduced the SS firing rate in a concentration-dependent manner (IC50: 43.4 µmol\L). Application of either a γ-aminobutyric acid type A (GABAA) receptor antagonist, SR95531 (20 μmol\L) or a glycine receptor antagonist strychnine (10 μmol\L) significantly attenuated but not abolished the etomidate-induced decrease in PC SS firing rate. However, co-application of SR95531 (20 μmol\L) and strychnine (10 μmol\L) abolished the etomidate-induced decrease in PC SS firing rate. Moreover, intraperitoneal injection of etomidate (3 mg/kg body weight) also induced a significant depression in PC SS firing rate, which was blocked by the co-application of SR95531 and strychnine on the cerebellar surface. These results indicate that both GABAA and glycine receptors are involved in the etomidate-induced decrease in PC SS firing rate in vivo in mice.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.